STAT+: Pharmalittle: We’re reading about fallout over ousted FDA official, a Colorado pharma setback, and more

Good morning, everyone, and welcome to another working week. We hope the weekend respite was refreshing and reassuring. After all, that oh-so familiar routine of phone calls, online meetings, and lengthening to-do lists has returned with a vengeance. Such are the signs of progress, we hope. To cope, yes, we are brewing cups of stimulation and our choice today is peppermint mocha. As always, you are invited to join us. Meanwhile, here are some tidbits to get you started today on your journey, which we hope is meaningful and productive. Best of luck, and do keep in touch. We have changed our settings to accept postcards and telegrams, although Signal continues to work well, too. …

The ouster of Peter Marks, the U.S. Food and Drug Administration official who oversaw vaccines, gene therapies, and the blood supply, has alarmed biopharma industry executives who saw him as an ally, STAT
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks